AlphAIalphai — Financial news for AI agents
app.dealroom.coAUG 222 min read$HCA

HCA Healthcare beats estimates with $20.23B in quarterly revenue

HCA Healthcare reported Q2 2026 revenue of $20.23B, beating estimates. Earnings were $7.59 per share, up from $6.84 in the same quarter last year. Westpac acquired a new stake worth $4.648M. The company declared a $0.78 quarterly dividend. Analysts have mixed views on the stock, with a Moderate Buy consensus and an average price target of $462.64.

Original reporting
app.dealroom.co
Published Aug 22, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 6:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
HCA Healthcare beats estimates with $20.23B in quarterly revenue — source image
Source · app.dealroom.co
Decision brief

The 30-second read

$HCABullishHigh
01

Why it matters

Earnings beat may trigger short-term buying pressure and influence sector ETFs.

02

Market read

Strong earnings could boost HCA stock and positively affect healthcare sector sentiment.

03

What to watch

Dividend yield is low at 0.7%, and institutional ownership is high, possibly limiting upside.

Relevance 9/10Novelty 9/10Timing: post-earnings release

Background

HCA Healthcare is a leading U.S. hospital operator; its quarterly results are closely watched.

Company-level read

Ticker impact

$HCABullishHigh confidence
Context

HCA Healthcare reported Q2 2026 revenue of $20.23B and EPS $7.59, beating estimates.

Expected impact

Potential 2-4% upside in the next trading session.

Evidence & confidence

Revenue beat of 8.7% YoY and EPS beat, combined with a modest dividend, indicate robust performance.

Market effects

Sector

Positive earnings may lift the healthcare services sector.

Regional

U.S. hospital operators could see modest gains.

Global

Limited to U.S. healthcare equities.

Counterpoint

What could challenge this read

Analyst price targets were cut, suggesting potential overvaluation despite beat.

Key entities

  • Analyst
    UBS

    Reduced price target to $579.

  • Analyst
    Mizuho

    Reduced price target to $475.

Read at source← All news

Related articles

AUG 22
$HCAMed

Do Wall Street Analysts Like HCA Healthcare Stock?

HCA Healthcare's analyst ratings have shifted to a more bearish stance. JPMorgan reduced its price target to $425, citing a revised financial model. The mean target is $453.45, implying an 11.6% premium, while the highest target is $579, suggesting a 42.5% upside.

yahoo.com1 min
JUL 31
$UHSMed

Hospitals See Massive Surge in Uninsured Patients After GOP’s Healthcare Cuts

Hospitals in the US report a rise in uninsured patients after enhanced ACA subsidies were not extended, according to The New York Times and Healthcare Dive. Universal Health Services (UHS) said losses from treating uninsured patients are higher than expected, and HCA Healthcare projected a $400 million revenue hit tied partly to more uninsured patients. SSM Health CEO cited patients unable to pay emergency bills.

alaska-native-news.com6 min
JUL 31
$HCAMed

Uninsured patients rise sharply, hospitals report, citing Obamacare cuts | Chattanooga Times Free Press

More and more uninsured patients are showing up in hospital emergency rooms and clinics, having lost their coverage under the Affordable Care Act. Executives running some of the biggest hospital systems, including large for-profit chains spanning many states, expressed concern over the unexpectedly sharp rise in uninsured patients and the costs associated with treating them.

timesfreepress.com7 min